WHO ICTRP trial
Prospective, multicentre, open-label study evaluating Fondaparinux (1,5 mg/day)…
EUCTR2007-001048-32-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2007-001048-32-FR |
|---|---|
| Public title | Prospective, multicentre, open-label study evaluating Fondaparinux (1,5 mg/day) in venous thromboembolic events prevention in patients with renal impairment defined by a creatinin clearance between 20 and 50 ml/min and undergoing a major orthopaedic surgery (hip fracture, total hip replacement and total knee replacement) |
| Scientific title | Prospective, multicentre, open-label study evaluating Fondaparinux (1,5 mg/day) in venous thromboembolic events prevention in patients with renal impairment defined by a creatinin clearance between 20 and 50 ml/min and undergoing a major orthopaedic surgery (hip fracture, total hip replacement and… |
| Primary sponsor | CHU SAINT-ETIENNE |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France |
| Conditions | Patients with renal impairment defined by a creatinin clearance between 20 and 50 ml/min and undergoing a major orthopaedic surgery (hip fracture, total hip replacement and total knee replacement) MedDRA version: 9.1 Level: LLT… |
| Interventions | Trade Name: Arixtra 1,5 mg/0,3 ml Pharmaceutical Form: Solution for injection INN or Proposed INN: Fondaparinux CAS Number: 114870-03-0 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 5- |
| Registration date | Mar 29, 2007 |
| Secondary IDs | 0701017 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: